Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

G.R. Hajer; G.M. Dallinga-Thie; L.C. van Vark-van der Zee; J.K. Olijhoek; F.L.J. Visseren

Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

Translated title of the contribution: Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

G.R. Hajer, G.M. Dallinga-Thie, L.C. van Vark-van der Zee, J.K. Olijhoek, F.L.J. Visseren

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
Original language	Undefined/Unknown
Pages (from-to)	870-877
Number of pages	8
Journal	Clinical Endocrinology
Volume	69
Issue number	6
Publication status	Published - 2008

Cite this

@article{6d7f3f2278e74d68a43ac7831068f36d,

title = "Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.",

author = "G.R. Hajer and G.M. Dallinga-Thie and {van Vark-van der Zee}, L.C. and J.K. Olijhoek and F.L.J. Visseren",

year = "2008",

language = "Undefined/Unknown",

volume = "69",

pages = "870--877",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell",

number = "6",

}

Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial. / Hajer, G.R.; Dallinga-Thie, G.M.; van Vark-van der Zee, L.C. et al.
In: Clinical Endocrinology, Vol. 69, No. 6, 2008, p. 870-877.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

AU - Hajer, G.R.

AU - Dallinga-Thie, G.M.

AU - van Vark-van der Zee, L.C.

AU - Olijhoek, J.K.

AU - Visseren, F.L.J.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0300-0664

VL - 69

SP - 870

EP - 877

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 6

ER -